Comparative biology of human and canine osteosarcoma

被引：0
作者：
Mueller, F.
Fuchs, B.
Kaser-Hotz, B.
机构：
[1] Univ Zurich, Vetsuisse Fac, Sect Diagnost Imaging & Radiat Oncol, CH-8057 Zurich, Switzerland
[2] Univ Zurich, Balgrist Univ Hosp, Dept Orthopaed, Zurich, Switzerland
来源：
ANTICANCER RESEARCH | 2007年 / 27卷 / 1A期
关键词：
osteosarcoma; comparative biology; dog model; review; TUMOR-SUPPRESSOR GENE; GROWTH-FACTOR-I; ALKALINE-PHOSPHATASE ACTIVITY; LIPOSOMAL MURAMYL TRIPEPTIDE; OSTEO-SARCOMA; APPENDICULAR OSTEOSARCOMA; PROGNOSTIC FACTORS; CELL-LINES; CYCLOOXYGENASE-2; EXPRESSION; ADJUVANT CHEMOTHERAPY;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Dogs with osteosarcoma provide an important model for the same disease in humans. In this report, the comparative nature of human and canine osteosarcoma including incidence and risk factors, clinical presentation and diagnosis, genetic abnormalities, biologic behaviour and prognostic factors, as well as treatment options are reviewed.
引用
收藏
页码：155 / 164
页数：10
相关论文
共 152 条
[81]   Tumor suppressor PTEN is mutated in canine osteosarcoma cell lines and tumors [J].
Levine, RA ;
Forest, T ;
Smith, C .
VETERINARY PATHOLOGY, 2002, 39 (03) :372-378
[82]   Inactivation of p53 and retinoblastoma family pathways in canine osteosarcoma cell lines [J].
Levine, RA ;
Fleischli, MA .
VETERINARY PATHOLOGY, 2000, 37 (01) :54-61
[83]   Identification of a novel germline MET mutation in dogs [J].
Liao, A. T. ;
McMahon, M. ;
London, C. A. .
ANIMAL GENETICS, 2006, 37 (03) :248-252
[84]   THE EFFECT OF ADJUVANT CHEMOTHERAPY ON RELAPSE-FREE SURVIVAL IN PATIENTS WITH OSTEOSARCOMA OF THE EXTREMITY [J].
LINK, MP ;
GOORIN, AM ;
MISER, AW ;
GREEN, AA ;
PRATT, CB ;
BELASCO, JB ;
PRITCHARD, J ;
MALPAS, JS ;
BAKER, AR ;
KIRKPATRICK, JA ;
AYALA, AG ;
SHUSTER, JJ ;
ABELSON, HT ;
SIMONE, JV ;
VIETTI, TJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (25) :1600-1606
[85]   Clinical and pathologic relevance of p53 index in canine osseous tumors [J].
Loukopoulos, P ;
Thornton, TR ;
Robinson, WF .
VETERINARY PATHOLOGY, 2003, 40 (03) :237-248
[86]   IGF-1 receptor contributes to the malignant phenotype in human and canine osteosarcoma [J].
MacEwen, EG ;
Pastor, J ;
Kutzke, J ;
Tsan, R ;
Kurzman, ID ;
Thamm, DH ;
Wilson, M ;
Radinsky, R .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2004, 92 (01) :77-91
[87]  
MacEwen EG, 2003, CLIN EXP METASTAS, V20, P421
[88]   THERAPY FOR OSTEO-SARCOMA IN DOGS WITH INTRAVENOUS-INJECTION OF LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE [J].
MACEWEN, EG ;
KURZMAN, ID ;
ROSENTHAL, RC ;
SMITH, BW ;
MANLEY, PA ;
ROUSH, JK ;
HOWARD, PE .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (12) :935-938
[89]  
Maitra A, 2001, LAB INVEST, V81, p4P, DOI 10.1002/1097-0142(20010801)92:3<677::AID-CNCR1370>3.0.CO
[90]  
2-V
45678910111213